Denis Chem Lab

Denis Chem Lab Forward P/E

The Forward P/E Ratio of Denis Chem Lab (537536.BO) as of Oct 22, 2026 is 12.74. In the previous year, Forward P/E Ratio was 13.26 — a change of -3.97% (lower).

Forward P/E

12.74

YoY

-3.97%

Last updated:

Forward P/E Ratio of Denis Chem Lab is 2025 12.74 . Forward P/E Ratio of Denis Chem Lab was 2024 13.26 . It decreases by -3.97% lower compared to the previous year.

The Denis Chem Lab Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
16.87 INR
Jan 1, 2019
25.42 INR
Jan 1, 2020
47.30 INR
Jan 1, 2021
17.10 INR
Jan 1, 2022
13.63 INR
Jan 1, 2023
9.60 INR
Jan 1, 2024
13.26 INR
Jan 1, 2025
12.74 INR
The Denis Chem Lab Forward P/E history
YEARForward P/EYoY
12.74-3.97%
13.26+38.14%
9.60-29.55%
13.63-20.32%
17.10-63.84%
47.30+86.10%
25.42+50.68%
16.87-66.24%
49.96-42.27%
86.54-459.39%
-24.08-128.10%
85.68—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Denis Chem Lab Stock analysis

What does Denis Chem Lab do? Denis Chem Lab Ltd. generates revenue through the manufacture and sale of transfusion solutions in bottles, including sterile intravenous injectables for human and veterinary use. The company offers a range of products such as carbohydrate solutions, sodium chloride solutions, potassium chloride solutions, and plasma volume expanders under its own brands. It also produces sterile intravenous injectables in volumes from 100 milliliters to 10 liters for direct sales to customers. Additionally, the firm manufactures contract products for multinational pharmaceutical companies, leveraging its facility for third-party production. The company's primary customers include healthcare providers and veterinary institutions that require sterile intravenous solutions. Its product portfolio targets both human and veterinary markets, with offerings like antibiotic solutions and dialysis solutions catering to specific medical needs. The firm's contract manufacturing services provide an additional revenue stream by supplying multinational pharmaceutical companies with custom-produced sterile injectables. Denis Chem Lab Ltd. focuses on manufacturing and selling its own branded products, such as carbohydrate in sodium chloride solutions and multi electrolyte solutions, while also engaging in contract manufacturing for multinational pharmaceutical companies. The company's production capabilities span from small-volume solutions to large 10-liter bottles, ensuring versatility in meeting diverse customer demands across healthcare and veterinary sectors. Denis Chem Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Denis Chem Lab stock

Forward P/E Ratio of Denis Chem Lab is 12.74 in 2025.

Forward P/E Ratio of Denis Chem Lab changed from 13.26 to 12.74, representing a -3.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Denis Chem Lab since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Denis Chem Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Denis Chem Lab

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Denis Chem Lab